Update: a briefing outlining the presentations by the speakers has been published.
Europol report on cybercrime and disinformation amid the COVID-19 pandemic.
During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union.
On 2 April, regulators from around the world joined the second workshop on COVID-19 organised by the European Medicines Agency (EMA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). Participants from more than 25 countries, representing 28 medicines regulatory authorities globally and experts from the World Health Organization and the European Commission discussed the available knowledge on possible treatments (drugs and biologics) for COVID-19,
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 29 March-4 April 2020 and includes updates on COVID-19, Ebola virus disease, and influenza.
Today, the European Commission has adopted a proposal to postpone by one year the date of application of the Medical Devices Regulation to allow Member States, health institutions and economic operators to prioritise the fight against the coronavirus pandemic. This decision takes into account the unprecedented challenges of the coronavirus pandemic and the need for an increased availability of vitally important medical devices across the EU whilst continuing to ensure patient health and safety until the new legislation becomes applicable.
The coronavirus pandemic is putting healthcare systems across the EU under unprecedented and increasing pressure. To support and encourage cross-border healthcare cooperation between national, regional and local authorities, the Commission has today issued practical guidance to Member States. Cooperation across borders can help ease the pressure on overburdened hospitals by transferring patients suffering from coronavirus for treatment in Member States where hospital places are available. The Commission will also support Member States or non-governmental organisations to send qualified teams of medical personnel to offer assistance across borders.
Defence ministers will hold a video conference on the military implications of the COVID-19 pandemic.
On 2 April, the Chair and the Coordinators of the INTA committee sent a letter to Trade Commissioner Hogan to express the committee’s support for the Commission’s implementing regulation on export authorisations for personal protective equipment.
Following the publication of its statement on the application of the prudential framework regarding default, forbearance and IFRS9 in light of COVID-19 measures, the European Banking Authority (EBA) published today more detailed guidance on the criteria to be fulfilled by legislative and non-legislative moratoria applied before 30 June 2020. The aim of these Guidelines is to clarify the requirements for public and private moratoria, which if fulfilled, will help avoid the classification of exposures under the definition of forbearance or as defaulted under distressed restructuring.
The outbreak of COVID-19 has significantly impacted the activities of EIOPA, NCAs and financial institutions, ranging from the need to assess implications to the market and propose immediate regulatory measures relevant for the current situation, to the deployment of business continuity plans.
The European Insurance and Occupational Pensions Authority (EIOPA) has published a statement on dividends distribution and variable remuneration policies in the context of COVID-19.
A summary of the consideration of amendments is available.